A Phase 1, First in Human, Open-label, Dose Escalation and Dose Expansion Study of TST005 in Patients with Locally Advanced or Metastatic Solid Tumors Read more
A Single Arm Phase II Study to Evaluate Treatment with Gevokizumab in Patients with Stage II/III Colon Cancer who are ctDNA-positive after Curative Surgery and Adjuvant Chemotherapy. Read more
A Phase 1a/1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PY314 as a Single Agent and In Combination with Pembrolizumab in Subjects with Advanced Solid Tumors Read more
A Phase 1, Multicenter, Open-Label Study of SQZ-AAC-HPV as Monotherapy and in Combination with Immune Checkpoint Inhibitors in HLA-A*02+ Patients with HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors? under Read more
A phase I, open-label, multicenter study to assess safety, tolerability, PK and efficacy of MK-1084 as monotherapy and in combination with pembrolizumab in subjects with KRASG12C mutant advanced solid tumors 1084-001 Read more
Phase I/Iia, First-In-Human (FIH), Open-Label, Dose Escalation Trial With Expansion Cohorts To Evaluate Safety And Preliminary Efficacy Of CLDN6 CAR-T +/- CLDN6 RNA-LPX In Patients With CLDN6-Positive Relapsed Or Refractory Advanced Solid Tumors Read more
Phase I/II clinical trial of combination of OX40 and HDAC inhibitor in patients with Stage IV NSCLC Read more
The Effects And Mechanisms Of TNF-α/TNFR2 In Regulatory T Cells On Microenvironment And Progression In Gastric Cancer Read more
